<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240718062453N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-08-27</date_registration>
      <primary_sponsor>The University of Faislabad</primary_sponsor>
      <public_title>Comparative Effects Of PIR Technique And SCS In Patients With Piriformis Syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Effects Of Post Isometric Relaxation Technique And Strain-Counterstrain In Patients With Piriformis Syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-18</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>66</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/78373</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Subjects were randomly allocated into two groups through lottery method. Participants were randomly allocated into two groups using the lottery method to ensure unbiased group assignment. Each participant was assigned a unique identifier, which was written on a slip of paper. These slips were placed into a container, mixed thoroughly, and drawn one by one. The first slip was assigned to Group A, the second to Group B, and this alternation continued until all participants were allocated. This method ensured equal chances of being assigned to either group, maintaining the integrity of the randomization process.</study_design>
      <phase>2</phase>
      <hc_freetext>piriformis syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1=will receive Positional Release Therapy. Intervention 2: Intervention group:2= Group B will receive Post isometric relaxation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is there is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Umaira ijaz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>samunadri</address>
        <city>Faislabad</city>
        <country1>Pakistan</country1>
        <zip>37300</zip>
        <telephone>+92 305 3275533</telephone>
        <email>2022-ms-pt-054@gmail.com</email>
        <affiliation>The University of Faislabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Umaira Ijaz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>samundari</address>
        <city>Faislabad</city>
        <country1>Pakistan</country1>
        <zip>37300</zip>
        <telephone>+92 305 3275533</telephone>
        <email>2022-ms-pt-054@gmail.com</email>
        <affiliation>The University Of Faislabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Pain in buttocks not more than 2 weeks
Numeric Pain Rating Scale (3-9 on scale)
Complain of Pain while sitting, standing, or lying longer than 15 to 20 minutes
Positive FAIR test
Positive Beatty test</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>pregnancy
SIJ pain
Lumbar radiculopathy
malignancy
rheumatoid disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1=will receive Positional Release Therapy</i_keyword>
      <i_keyword>Intervention group:2= Group B will receive Post isometric relaxation</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>A primary outcome measure was pain which was assessed by Numeric Pain Rating Scale (NPRS). Timepoint: This brief assessment ensured minimal disruption to the therapy sessions and provided a quick and effective way to monitor pain changes over time. measurement was taken before intervention, at 2nd week , 4rth week. Method of measurement: Pain, the primary outcome measure, was assessed using the Numeric Pain Rating Scale (NPRS). Participants rated their pain on a scale from 0 (no pain) to 10 (worst possible pain). Measurements were taken at four time points: baseline (before the start of the intervention), at the end of the 2nd week, at the end of the 4th week (after the intervention period), and at the 8th week follow-up. This method ensured a comprehensive evaluation of pain reduction over time.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Secondary outcome measures were hip abduction and internal rotation range of motion that was measured through universal goniometer and Lower Extremity Functional Status was assessed by Lower Extremity Functional Scale (LEFS). Timepoint: 1.Hip Abduction and Internal Rotation Range of Motion: Measured using a universal goniometer. Each measurement typically took about 5-10 minutes per hip, including positioning the participant, taking measurements, and recording results. outcome measurement was taken before treatment , at 2nd week and at 4th week.                                                                                                                               Lower Extremity Functional Status: Assessed using the Lower Extremity Functional Scale (LEFS). Completing the LEFS questionnaire generally took about 5 minutes per participant.In total, assessing both range of motion and functional status would take approximately 10-15 minutes per participant per assessment session.outcome measurement was taken before treatment , at 2nd week and at 4th week. Method of measurement: For secondary outcome measures, hip abduction and internal rotation range of motion were assessed using a universal goniometer.                                                                                                                 Lower Extremity Functional Status was assessed using the Lower Extremity Functional Scale (LEFS). Participants completed a 20-item questionnaire evaluating their ability to perform daily activities, with responses scored from 0 (extreme difficulty or unable to perform) to 4 (no difficulty).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Faislabad</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-05</approval_date>
        <contact_name>research and ethics technical commette</contact_name>
        <contact_address>Faisal Town, West Canal Road, Faisalabad Faisalabad punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
